CN Patent
CN103040976B — 一种促进面神经损伤外科吻合术后康复的药物
Assigned to Liu Jianzhen · Expires 2014-01-15 · 12y expired
What this patent protects
本发明公开了一种促进面神经损伤外科吻合术后康复的药物,以解决面神经损伤外科吻合术后康复问题。其特征在于由多种中药加工而成,其原料配方和重量配比为:松萝10~20份,石香葇8~15份,肿节风8~15份,千里光6~10份,木瓜6~10份,穿山甲8~15份,升麻6~10份,桂枝3~6份,石胆3~6份。临床实验证明,本发明用于面神经损伤外科吻合术后康复具有疗效好和安全性较高的特点,值得临床应用、推广。
USPTO Abstract
本发明公开了一种促进面神经损伤外科吻合术后康复的药物,以解决面神经损伤外科吻合术后康复问题。其特征在于由多种中药加工而成,其原料配方和重量配比为:松萝10~20份,石香葇8~15份,肿节风8~15份,千里光6~10份,木瓜6~10份,穿山甲8~15份,升麻6~10份,桂枝3~6份,石胆3~6份。临床实验证明,本发明用于面神经损伤外科吻合术后康复具有疗效好和安全性较高的特点,值得临床应用、推广。
Drugs covered by this patent
- Tryptyr (ACOLTREMON) · Alcon Labs Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.